what does eris lifesciences do

Eris Lifesciences Limited is engaged in the manufacture and marketing of pharmaceutical products, specifically focusing on branded formulations and partnering for products like Semaglutide in India.

when was eris lifesciences established

Eris Lifesciences was established in 2006, making it the youngest among the top 20 companies in the Indian pharmaceutical market.

who is the owner of eris lifesciences

Eris Lifesciences is a publicly listed company on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), with a current market capitalization of ₹20,138 crore.

what is eris lifesciences

Eris Lifesciences is a leading Indian pharmaceutical company ranked #20 in the Indian Pharmaceutical Market (IPM) by IQVIA, specializing in cardio-metabolic formulations and exports.

where is eris located

Eris Lifesciences is headquartered in Greater Noida, Uttar Pradesh, and has a significant presence in the Indian pharmaceutical industry.

Eris Lifesciences Limited (ERIS) Share Price Today — ₹1,365.75

Eris Lifesciences Limited (ERIS) live stock price is ₹1,365.75. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Eris Lifesciences Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Eris Lifesciences Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

ERIS

BSE

Eris Lifesciences Limited

Healthcare· Pharmaceuticals & Biotechnology· INE406M01024· Scrip: 540596

EN हिन्दी ગુજરાતી मराठी

₹1,365.75

▲ 6.90 (+0.00%)

2026-06-10

BSE

₹1,365.75

▲ 6.90

+0.00%

233 trading days · 1Y period

TODAY (BSE)

Open1,376.40

High1,384.80

Low1,363.40

Prev Close1,372.65

Volume870

Value₹0.1Cr

L: 1,363.40H: 1,384.80

Info

Face Value₹1

Listed2017-06-29

ISININE406M01024

SeriesA

BSE Scrip540596

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-1.56%

PAT-9.78%

EPS-8.62%

Profitability

EBITDA Margin39.0%

Net Margin11.9%

TTM EBITDA M.34.3%

TTM Net M.12.9%

Dividend

Yield—

Latest DPS₹7.35

Payout Ratio119.5%

Growth+0.00%

TTM Revenue

₹2737 Cr

TTM EBITDA

₹937 Cr

TTM PAT

₹352 Cr

TTM EPS

₹24.21

Rev/Share

₹197.6

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	727 Cr	616 Cr	284 Cr	116 Cr	87 Cr	₹6.15
2024-09-30	739 Cr	617 Cr	302 Cr	129 Cr	96 Cr	₹6.73
2024-06-30	720 Cr	606 Cr	191 Cr	115 Cr	89 Cr	₹6.11
2024-03-31	551 Cr	489 Cr	161 Cr	77 Cr	80 Cr	₹5.22
2023-12-31	486 Cr	375 Cr	194 Cr	116 Cr	101 Cr	₹7.55
2023-09-30	505 Cr	383 Cr	189 Cr	126 Cr	122 Cr	₹9.08
2023-03-31	403 Cr	328 Cr	134 Cr	76 Cr	61 Cr	₹4.81
2022-12-31	423 Cr	319 Cr	146 Cr	107 Cr	100 Cr	₹7.49

Shareholding Pattern

CURRENT — 2026-03-31

Promoter53.9%

FII6.4%

DII20.4%

Public46.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-02-13	Dividend	Interim Dividend - Rs 7.35 Per Share
2024-09-17	Other	Annual General Meeting
2023-09-15	Other	Annual General Meeting
2022-08-23	Other	Annual General Meeting
2022-08-11	Dividend	Interim Dividend- Rs 7.35 Per Share
2021-08-23	Other	Annual General Meeting
2021-08-05	Dividend	Interim Dividend - Rs 6.01 Per Share
2020-09-18	Other	Annual General Meeting
2020-08-13	Dividend	Interim Dividend - Rs 5.50 Per Share
2020-03-19	Dividend	Interim Dividend - Rs 2.87 Per Share
2019-09-18	Other	Annual General Meeting
2019-07-12	Buyback	Buyback
2018-09-19	Other	Annual General Meeting
2017-09-20	Other	Annual General Meeting

Earnings Transcripts

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

20 May 2026NSE28K chars

Read →

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

12 Nov 2025NSE40K chars

Read →

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

5 Aug 2025NSE30K chars

Read →

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

19 May 2025NSE22K chars

Read →

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

4 Feb 2025NSE28K chars

Read →

Eris Lifesciences Limited has informed the Exchange about Investor Presentation

13 Feb 2024NSE20K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	1,371.00	1,384.00	1,363.20	1,366.90	43,873
2026-06-03	1,369.90	1,412.00	1,360.00	1,397.10	1.13L
2026-05-27	1,362.20	1,374.90	1,350.00	1,350.80	37,418
2026-05-26	1,354.90	1,370.00	1,323.10	1,361.40	1.06L
2026-05-25	1,344.90	1,358.00	1,339.20	1,353.50	63,907
2026-05-22	1,394.00	1,397.90	1,341.10	1,343.80	1.29L
2026-05-21	1,489.10	1,530.00	1,372.30	1,385.90	6.66L
2026-05-20	1,345.00	1,495.00	1,340.10	1,458.20	16.05L
2026-05-19	1,340.80	1,356.40	1,322.00	1,336.20	41,101
2026-05-18	1,371.10	1,385.00	1,331.00	1,340.80	34,423
2026-05-15	1,369.60	1,410.00	1,355.00	1,370.90	1.82L
2026-05-14	1,349.90	1,378.90	1,340.90	1,373.90	38,481
2026-05-13	1,357.60	1,379.00	1,322.50	1,330.60	77,196
2026-05-12	1,376.40	1,385.00	1,350.20	1,357.60	45,229
2026-05-11	1,412.80	1,419.50	1,367.10	1,376.40	42,712
2026-05-08	1,383.00	1,410.00	1,381.60	1,386.10	49,771
2026-05-07	1,382.00	1,395.60	1,374.00	1,383.20	1.33L
2026-05-06	1,360.00	1,384.10	1,358.10	1,371.90	42,356
2026-05-05	1,353.70	1,364.90	1,350.70	1,358.70	21,114
2026-05-04	1,322.90	1,356.50	1,322.90	1,353.60	37,205
2026-04-30	1,317.90	1,337.20	1,308.00	1,322.90	1.20L
2026-04-29	1,335.00	1,361.80	1,307.00	1,316.20	73,396
2026-04-28	1,359.00	1,359.00	1,200.00	1,327.60	1.42L
2026-04-27	1,353.00	1,393.80	1,340.30	1,358.20	2.53L
2026-04-24	1,399.80	1,416.30	1,359.80	1,373.50	1.41L
2026-04-23	1,340.50	1,399.40	1,336.40	1,395.70	2.34L
2026-04-22	1,376.00	1,384.20	1,338.40	1,352.80	1.78L
2026-04-21	1,445.00	1,450.40	1,339.10	1,376.00	5.86L
2026-04-20	1,445.50	1,460.00	1,417.30	1,432.40	56,908
2026-04-17	1,452.00	1,472.90	1,440.10	1,445.50	66,310

Frequently Asked Questions

About

Eris Lifesciences Limited is a prominent Indian pharmaceutical company specializing in the manufacturing and marketing of branded pharmaceutical formulations, with a strong focus on the cardio-metabolic segment. Established in 2007, the company has quickly risen to become one of the youngest and fastest-growing entities in the Indian pharmaceutical market, achieving a leading position in its core therapeutic area within just 17 years.